Tessera Defense and Homeland Security Inc.

Aktienanalyse zu Tessera Defense and Homeland Security Inc. (HLSQ)

$0.134

+0.011 (+8.06%)Zum Schluss

Loading chart…
Hoch
0.147
Eröffnung
0.142
Volumengewichteter Durchschnittskurs
0.14
Volumen
310.94K
Marktkap.
—
Tief
0.130
Umsatz
42.61K
EV/EBITDA, TTM
0.00

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

thlsq.ai

KI-Analyse of Tessera Defense and Homeland Security Inc. (HLSQ)

Verkaufen

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Tessera Defense and Homeland Security Inc. (HLSQ) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

Event-Zeitleiste

2026-10-20 (ET)

08:30:00

Zorronet Receives Initial Order from Global Defense Company

2026-10-15 (ET)

10:00:00

Tessera Defense Secures Option to Acquire Controlling Stake in RT LTA Systems

News

HLSQ FAQ – beantwortet von Alphio AI

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln